Skip to main content
Senseonics Holdings, Inc. logo

Senseonics Holdings, Inc. — Investor Relations & Filings

Ticker · SENS ISIN · US81727U1051 LEI · 549300RCH6Z07TBHJ258 US Manufacturing
Open in API
Filings indexed 846 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country US United States of America
Listing US SENS

About Senseonics Holdings, Inc.

https://www.senseonics.com/

Senseonics Holdings, Inc. is a medical technology company focused on the design, development, and commercialization of glucose monitoring products for people with diabetes. The company's primary offering is the Eversense® Continuous Glucose Monitoring (CGM) System, distinguished as the first and only long-term, implantable glucose sensor. The system consists of a sensor inserted subcutaneously, a removable smart transmitter worn over the sensor, and a mobile application for displaying real-time glucose data, trends, and alerts. The Eversense system is designed to provide continuous glucose monitoring for up to six months from a single sensor, aiming to reduce the frequency of sensor insertions compared to traditional CGM systems.

Recent filings

Filing Released Lang Actions
FORM SD
Regulatory Filings Classification · 82% confidence The document is an SEC Form SD (“Specialized Disclosure Report”) filed under Rule 13p-1 of the Securities Exchange Act for conflict minerals disclosure. It is a specific regulatory compliance filing without substantive financial statements. Under our taxonomy, such SEC regulatory compliance disclosures fall into the Regulatory Filings (RNS) category.
2026-06-01 English
FORM S-8
Share Issue/Capital Change Classification · 88% confidence The document is a Securities and Exchange Commission registration statement on Form S-8, used to register shares of common stock for issuance under employee benefit plans (2026 Equity Incentive Plan, 2016 ESPP, 2015 Plan). Form S-8 relates to the company registering new shares for issuance, which is a capital change/share issuance filing. Therefore, it best fits the Share Issue/Capital Change category.
2026-05-20 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 88% confidence The document is a Form 8-K current report disclosing the results of matters submitted to a vote of security holders at the Annual Meeting (Item 5.07) and related charter amendment (Item 5.03). It provides detailed voting tallies for each proposal. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-20 English
424B5 - Senseonics Holdings, Inc. (0001616543) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement and accompanying prospectus related to a shelf registration statement on Form S-3 filed with the SEC. It contains detailed information about an offering of common stock, including use of proceeds, dividend policy, risk factors, description of securities, underwriting, and legal matters. The document is focused on capital raising and securities offering terms rather than financial results, management discussion, or regulatory compliance filings. It is not an annual or quarterly report, earnings release, or management report. The presence of terms like "prospectus supplement," "use of proceeds," and "offering of common stock" clearly indicates this is a capital markets document related to financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence level.
2026-04-30 English
ARS - Senseonics Holdings, Inc. (0001616543) (Filer)
Annual Report
2026-04-06 English
DEF 14A - Senseonics Holdings, Inc. (0001616543) (Filer)
Proxy Solicitation & Information Statement
2026-04-06 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.